Assess whether the carve-out is operable on day one (2afb9b)

SITUATION A strategic buyer looking at a carve-out from a conglomerate cannot treat an HSR second-request rumor as incidental context on regulatory-approval critical-path calendar. Customer-contract risk reviewer must close the carve-out is operable from that extract under M&A Due Diligence / Separation and Integration.

DECISION Customer-contract risk reviewer in a strategic buyer looking at a carve-out from a conglomerate must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after an HSR second-request rumor.

HYPOTHESES TO TEST 1. Customer-contract risk reviewer can defend Proceed from regulatory-approval critical-path calendar after an HSR second-request rumor in a M&A Due Diligence challenge. 2. Customer-contract risk reviewer cannot defend Proceed from regulatory-approval critical-path calendar; Reprice is what the extract actually supports after an HSR second-request rumor. 3. An HSR second-request rumor never reached the population in regulatory-approval critical-path calendar — reopen intake, do not close the carve-out is operable. 4. Two facts in regulatory-approval critical-path calendar after an HSR second-request rumor conflict for customer-contract risk reviewer; hold this Separation and Integration file.

ANALYSIS REQUIRED 1. Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to the carve-out is operable. 2. Name the document customer-contract risk reviewer still needs before signing. 3. Test whether an HSR second-request rumor is a diligence gap, a price chip, or a walk-away. 4. For this M&A Due Diligence Separation and Integration file, read regulatory-approval critical-path calendar against an HSR second-request rumor and write the one fact that would move the carve-out is operable for customer-contract risk reviewer.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Separation and Integration packet (regulatory-approval critical-path calendar after an HSR second-request rumor). Lead with the M&A Due Diligence option regulatory-approval critical-path calendar can support after an HSR second-request rumor, then the two facts that force it, then the Monday action for customer-contract risk reviewer in a strategic buyer looking at a carve-out from a conglomerate.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in regulatory-approval critical-path calendar, then the action for customer-contract risk reviewer - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - Missing page in regulatory-approval critical-path calendar after an HSR second-request rumor, if any - Regulatory or exam hook Separation and Integration would cite